StockData
Trulieve Cannabis Corp. logo

Trulieve Cannabis Corp. (TRLV) stock

TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3033% below fair value
$10.07−0.26 (-2.52%)

Close on Nov 17, 2026Market cap $1.94BP/E –Yield –

Trulieve Cannabis cash

Cash and short-term investments held at the end of each period.

Trulieve Cannabis's cash was $325.42M at Jun 30, 2026. For fiscal 2025 it was $255.54M, down 14.6% from the year before. The highest annual figure on record is $299.20M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$255.54M-14.6%
FY2024Dec 31, 2024$299.20M+48.6%
FY2023Dec 31, 2023$201.37M-2.8%
FY2022Dec 31, 2022$207.19M-8.6%
FY2021Dec 31, 2021$226.63M+54.5%
FY2020Dec 31, 2020$146.71M+59.8%
FY2019Dec 31, 2019$91.81M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$325.42M-17.1%
Q1 FY2026Mar 31, 2026$352.88M+7.4%
Q4 FY2025Dec 31, 2025$255.54M-14.6%
Q3 FY2025Sep 30, 2025$449.20M+41.3%
Q2 FY2025Jun 30, 2025$392.58M+10.5%
Q1 FY2025Mar 31, 2025$328.45M+2.5%
Q4 FY2024Dec 31, 2024$299.20M+48.6%
Q3 FY2024Sep 30, 2024$317.85M+65.4%
Q2 FY2024Jun 30, 2024$355.18M+133.1%
Q1 FY2024Mar 31, 2024$320.31M+72.5%
Q4 FY2023Dec 31, 2023$201.37M-2.8%
Q3 FY2023Sep 30, 2023$192.16M+90.9%
Q2 FY2023Jun 30, 2023$152.37M-8.5%
Q1 FY2023Mar 31, 2023$185.64M-30.3%
Q4 FY2022Dec 31, 2022$207.19M-8.6%
Q3 FY2022Sep 30, 2022$100.66M-52.9%
Q2 FY2022Jun 30, 2022$166.54M-42.4%
Q1 FY2022Mar 31, 2022$266.40M+64.0%
Q4 FY2021Dec 31, 2021$226.63M+54.5%
Q3 FY2021Sep 30, 2021$213.57M+132.6%
Q2 FY2021Jun 30, 2021$289.24M–
Q1 FY2021Mar 31, 2021$162.45M–
Q4 FY2020Dec 31, 2020$146.71M–
Q4 FY2019Dec 31, 2019$91.81M–

More Trulieve Cannabis figures

See a number that looks wrong?